[1] 刘玥昕, 吴骁, 关蓉, 等. 大黄及牛黄解毒片大鼠给药后血浆中大黄活性成分的药代动力学比较研究[J]. 中国药科大学学报, 2018, 49(4): 449
LIU YX, WU X, GUAN R, et al. Comparative pharmacokinetics of active anthraquinones ingredients after oral administration of Rhei Radix et Rhizoma and Niuhuang Jiedu tablets to rats[J]. J China Pharm Univ, 2018, 49(4): 449
[2] 中华人民共和国药典 2020年版. 一部[S]. 2020: 694
ChP 2020. Vol Ⅰ[S]. 2020: 694
[3] 金鹏飞, 梁晓丽, 夏路风, 等. ICP-MS研究牛黄解毒片中20种微量元素的总量及在水和胃肠液中的溶出特性[J]. 药物分析杂志, 2014, 34(6): 985
JIN PF, LIANG XL, XIA LF, et al. Study on total contents of 20 trace elements in Niuhuang Jiedu tablets and their extract rates in water and gastrointestinal fluids by ICP-MS[J]. Chin J Pharm Anal, 2014, 34(6): 985
[4] LIU HB, YE F, SUN Q, et al. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro[J]. J Enzyme Inhib Med Chem, 2021, 36(1): 497
[5] 郭玲玲, 刘毅, 禄梦杰, 等. HPLC法同时测定陕西产不同生长年限野生和栽培黄芩中9种化学成分的含量[J]. 中草药, 2018, 49(4): 935
GUO LL, LIU Y, LU MJ, et al. Simultaneous determination of nine components of Scutellaria baicalensis in different habitats and growth years by HPLC[J]. Chin Tradit Herb Drugs, 2018, 49(4): 935
[6] WU X, WU SH, LIU YX, et al. Health risk assessment of arsenic in Realgar and Niu Huang Jie Du tablets based on pharmacokinetic study[J]. J Trace Elem Med Biol, 2018, 48: 81
[7] 黄玉普, 吴大章, 王森. 黄芩的药理作用及其药对研究进展[J]. 中国药业, 2022, 31(15): 129
HUANG YP, WU DZ, WANG S. Research progress on pharmacological action of Scutellariae Radix and its drug pair[J]. China Pharm, 2022, 31(15): 129
[8] FENG Z, ZHOU J, SHANG X, et al. Comparative research on stability of baicalin and baicalein administrated in monomer and total flavonoid fraction form of Radix Scutellariae in biological fluids in vitro[J]. Pharm Biol, 2017, 55(1): 1177
[9] 刘廷, 狄留庆, 李娟, 等. 双黄连制剂中酚酸与黄酮类成分的含量测定及药代动力学分析[J]. 中国实验方剂学杂志, 2016, 22(18): 82
LIU T, DI LQ, LI J, et al. Determination and pharmacokinetic analysis of phenolic acids and flavonoids after oral administration of Shuanghuanglian preparation by UPLC-MS/MS[J]. Chin J Exp Tradit Med Form, 2016, 22(18): 82
[10] 赵宏兴, 王鑫, 刘有平, 等. LC-MS/MS法研究加味左金丸在大鼠体内的药动学[J]. 沈阳药科大学学报, 2021, 38(7): 668
ZHAO HX, WANG X, LIU YP, et al. Study on the pharmacokinetics of Jiawei Zuojin Wan in rats using LC-MS/MS[J]. J Shenyang Pharm Univ, 2021, 38(7): 668
[11] 杨培, 林龙飞, 田宇, 等. 生物样品测定分析方法中提取回收率的探讨[J]. 中华中医药杂志, 2015, 30(3): 722
YANG P, LIN LF, TIAN Y, et al. Discussion of recovery in biological sample determination methodology[J]. China J Tradit Chin Med Pharm, 2015, 30(3): 722
[12] 林龙飞, 陈功森, 李慧, 等. 黄芩-黄连煎煮共沉淀的物质基础、形貌以及对煎煮液体内过程的影响研究[J]. 中国中药杂志, 2023, 48(21): 5790
LIN LF, CHEN GS, LI H, et al. Composition and morphology of Sutellariae Radix-Coptidis Rhizoma decoction co-precipitate and effect on in vivo behavior of decocting liquid[J]. China J Chin Mater Med, 2023, 48(21): 5790
[13] 周严严, 顾欣如, 李涛, 等. 蒲地蓝消炎口服液活性成分在大鼠体内的药代动力学过程及对肝脏药物代谢酶的影响[J]. 中国中药杂志, 2019, 44(22): 4932
ZHOU YY, GU XR, LI T, et al. Pharmacokinetics of active ingredients of Pudilan Xiaoyan oral liquid in rats and effect on liver drug-metabolizing enzymes[J]. China J Chin Mater Med, 2019, 44(22): 4932
[14] 郑蓉, 张淇淞, 胡雪黎, 等. 多药耐药相关蛋白2对汉黄芩素及其主要Ⅱ相代谢产物药动学特征的影响[J]. 中草药, 2022, 53(21): 6779
ZHENG R, ZHANG QS, HU XL, et al. Effect of multidrug resistance protein 2 on pharmacokinetics of wogonin and its major phase Ⅱ metabolites[J]. Chin Tradit Herb Drugs, 2022, 53(21): 6779
[15] 汤泓, 汤丽玲, 徐瑞娟, 等. 部分黄酮类化合物的Ⅱ相代谢产物及其药理活性研究进展[J]. 中国新药杂志, 2012, 21(2): 144
TANG H, TANG LL, XU RJ, et al. Phase Ⅱ metabolites of several flavonoids and their pharmacological activities[J]. Chin J New Drugs, 2012, 21(2): 144
[16] 杨迪, 袁婷婷, 干舒蕾, 等. 静脉注射黄芩苷、黄芩素在大鼠体内的药代规律比较研究[J]. 中国临床药理学与治疗学, 2017, 22(4): 394
YANG D, YUAN TT, GAN SL, et al. Comparative study on pharmacokinetics of baicalin and baicalin after intravenous injection in rats[J]. Chin J Clin Pharmacol Ther, 2017, 22(4): 394
[17] WU X, YAN RN, GUAN R, et al. Arsenic-related health risk assessment of realgar-containing Niuhuangjiedu tablets in healthy volunteers po administration [J]. Front Pharmacol, 2022, 12: 761801
[18] 朱慧琳, 林超, 彭琳秀, 等. 大鼠肠道菌群对雄黄中砷体内行为的影响研究[J]. 药物分析杂志, 2021, 42(7): 43
ZHU HL, LIN C, PENG LX, et al. Effects of rat gut microbiota on the behavior of Realgar in vivo[J]. Chin J Pharm Anal, 2021, 42(7): 43
[19] 闫晶超, 刘兆明, 王天明, 等. 泻心汤黄酮类成分在大鼠体内的药代动力学研究[J]. 药学学报, 2007, 42(7): 722
YAN JC, LIU ZM, WANG TM, et al. Pharmacokinetics of flavonoids from Xiexin decoction in rats[J]. Acta Pharm Sin, 2007, 42(7): 722
[20] 李涛, 王怡薇, 王彦礼, 等. 黄芩汤血浆中多成分LC-MS法测定及其药代动力学特征研究[J]. 药学学报, 2013, 48(6): 917
LI T, WANG YW, WANG YL, et al. LC-MS quantification and pharmacokinetics of the multi-constituents of Huangqin Tang in rat plasma after different single oral doses[J]. Acta Pharm Sin, 2013, 48(6): 917
[21] 金维缘. HPLC-MS测定黄酮类成分分析方法的建立及其在雄黄-黄芩药动学研究中的应用[D]. 沈阳: 中国医科大学, 2020
JIN WY. Establishment of an HPLC-MS Method for the Determination of Flavonoids and Its Application in the Pharmacokinetic Study on Realgar and Scutellaria Combinations[D]. Shenyang: China Medical University, 2020
[22] 王沛明, 陈文, 张祎, 等. 基于p38MAPK通路初探大黄黄芩配伍对内毒素血证模型大鼠肝脏炎症的调节机制[J]. 中国中药杂志, 2016, 41(18): 3425
WANG PM, CHEN W, ZHANG Y, et al. Mechanism of Rhei Radix et Rhizoma combined with Scutellariae Radix on liver inflammation in rats with endotoxin disease based on p38MAPK pathway [J]. China J Chin Mater Med, 2016, 41(18): 3425
